Nerve Growth Factor and Transient Receptor Potential (TRPV1) Channel in Diabetic

糖尿病患者的神经生长因子和瞬时受体电位 (TRPV1) 通道

• 批准号: 7457520
• 负责人: Vickram Ramkumar
• 金额: $ 21.68万
• 依托单位: SOUTHERN ILLINOIS UNIVERSITY SCH OF MED
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-04-01 至 2008-07-18
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7457520
• 关键词: 4-ethoxymethylene-2-phenyl-2-oxazoline-5-one; Amputation; Analgesics; Animals; Biochemical; C57BL/6 Mouse; Cell physiology; Characteristics; Chronic; Complication; Coupled; Cultured Cells; Data; Development; Diabetes Mellitus; Diabetic mouse; Disease; Enzyme-Linked Immunosorbent Assay; Esthesia; Goals; Healed; Hyperalgesia; Hypersensitivity; In Vitro; Injection of therapeutic agent; Insulin; Insulin-Dependent Diabetes Mellitus; Intervention; Lead; Measures; Mechanics; Mediating; Messenger RNA; Modeling; Molecular Biology Techniques; Mus; NADPH Oxidase; Nerve Fibers; Nerve Growth Factors; Neurons; Pain; Pathway interactions; Patients; Perception; Peripheral; Peripheral Nervous System Diseases; Pharmaceutical Preparations; Pharmacotherapy; Phenotype; Preparation; Production; Protein Overexpression; Proteins; Public Health; Reactive Oxygen Species; Role; Sampling; Sensory; Sensory Receptors; Skin; Skin Tissue; Spinal Ganglia; Stimulus; Superoxides; System; TRPV1 gene; Tactile; Testing; Thermal Hyperalgesias; Transducers; Transgenic Organisms; Ulcer; afferent nerve; base; diabetic; glycemic control; healing; human AKAP13 protein; human CYBA protein; in vivo; iodoresiniferatoxin; mouse model; neutrophil cytosol factor 67K; novel; protein expression; receptor; response; sensor; superoxide-generating NADPH oxidase; type I diabetic

DESCRIPTION (provided by applicant): Diabetic peripheral neuropathy (DPN) is a common chronic complication of type 1 diabetes, characterized by progressive loss of thermal, tactile and pain sensations. The loss of peripheral sensations, coupled with impaired microvascular function in DPN can contribute to non-healing ulcers and lead to amputations. The goal of this study is to determine the mechanism(s) involved in altered thermal sensation in DPN. One hypothesis states that DPN results from altered nerve growth factor (NGF) trophic support to dorsal root ganglion (DRG) neurons. We believe that NGF regulates a thermal sensor protein, transient receptor potential channel (TRPV1), presumably by activating the NADPH oxidase superoxide generating system. Accordingly, we propose that an increase in NGF early in diabetes mediates thermal hypersensitivity, while low NGF levels or damage to sensory nerves as the disease progresses leads to sensory loss. We will test this hypothesis based on the specific aims outlined. Aim 1. To determine whether NGF regulates thermal sensation, the expression of TRPV1 and NADPH oxidase subunits in vivo. This aim will test if in vivo administration of NGF promotes hyperalgesia and whether this increases TRPV1 and NADPH oxidase subunit expression. Mice will be administered NGF by intraplantar injections, followed by analgesic testing 24 h later. DRGs and hindpaw skin obtained from vehicle and NGF treated mice will be collected to determine TRPV1 and NADPH oxidase mRNA and protein expression. Aim 2. To determine if altered thermal sensitivity in diabetes is associated with changes NGF, TRPV1 and the expression and activity of NADPH oxidase subunits. Using a double transgenic mouse model of type 1 diabetes we will measure the levels of NGF in lysates of DRGs and skin preparations, followed by measuring TRPV1 and NADPH oxidase expression using biochemical and molecular biology techniques. Preliminary studies indicate increased levels of TRPV1 in DRG neurons and hind paw skin samples correlates positively with the hyperalgesic response. Aim 3. To determine whether NGF or insulin therapy restores normal thermal sensitivity and the normal expression of TRPV1 and NADPH oxidase subunits in diabetic mice. Based on the hypothesis that a deficiency in NGF produces the hypoalgesic phenotype characteristic of type 1 diabetic mice, we will administer NGF or insulin (to maintain adequate glycemic control) to these animals and determine if it restores normal thermal sensation. The thermal thresholds of euglycemic controls and diabetic animals will be determined prior to and following administering either vehicle, NGF and insulin or a combination of these agents. The data obtained from this study would provide a better understanding of the role of NGF and the TRPV1 receptor in the controlling thermal sensations thermal in DPN. PUBLIC HEALTH RELEVANCE: The proposed project will focus on understanding some of the changes in nerve cell function, which lead to loss of pain perception in patients with diabetes, a complication termed diabetic peripheral neuropathy. We believe that the information gained by this study could contribute significantly to our appreciation of this disease and contribute to the development of novel drug therapies.

描述（由申请人提供）：糖尿病外周神经病（DPN）是1型糖尿病的常见慢性并发症，其特征是热，触觉和疼痛感觉的逐渐丧失。外围感觉的丧失，与DPN中的微血管功能受损相结合会导致非污染溃疡并导致截肢。这项研究的目的是确定DPN中热感觉改变的机制。一个假设指出，DPN是由对背根神经（DRG）神经元的神经生长因子（NGF）的营养支持改变引起的。我们认为NGF调节热传感器蛋白，瞬态受体电势通道（TRPV1），大概是通过激活NADPH氧化酶超氧化物生成系统而调节。因此，我们建议糖尿病早期NGF的增加会介导热超敏反应，而随着疾病的发展，NGF的水平低或对感觉神经的损害会导致感觉丧失。我们将根据概述的具体目的检验该假设。目的1。确定NGF是否调节热感觉，在体内TRPV1和NADPH氧化酶亚基的表达。该目标将测试NGF的体内给药是否促进了痛觉过敏，以及这是否会增加TRPV1和NADPH氧化酶亚基的表达。小鼠将通过注射内注射NGF给予NGF，然后在24小时后进行镇痛测试。将收集从车辆和NGF处理的小鼠获得的DRG和后爪皮，以确定TRPV1和NADPH氧化酶mRNA和蛋白质表达。目标2。确定糖尿病中的热敏感性是否与NGF，TRPV1的变化以及NADPH氧化酶亚基的表达和活性有关。使用1型糖尿病的双转基因小鼠模型，我们将测量DRG和皮肤制剂裂解物的NGF水平，然后使用生化和分子生物学技术测量TRPV1和NADPH氧化酶表达。初步研究表明，DRG神经元中TRPV1的水平增加，后爪皮肤样品与高过性反应呈正相关。目标3。确定NGF或胰岛素治疗是否恢复糖尿病小鼠中TRPV1和NADPH氧化酶亚基的正常热敏感性和正常表达。基于以下假设：NGF的缺乏会产生1型糖尿病小鼠的低凝固性表型特征，我们将对这些动物进行NGF或胰岛素（以维持足够的血糖控制）并确定它是否恢复正常的热感觉。在施用媒介物，NGF和胰岛素或这些药物的组合之前，将确定葡萄糖控制和糖尿病动物的热阈值。从这项研究中获得的数据将更好地理解NGF和TRPV1受体在DPN中的热感觉中的作用。 公共卫生相关性：拟议的项目将集中于了解神经细胞功能的某些变化，这会导致糖尿病患者的疼痛感知损失，这是一种称为糖尿病周围神经病的并发症。我们认为，这项研究获得的信息可以极大地促进我们对这种疾病的欣赏，并有助于新型药物疗法的发展。